The Medicines Company Reports Third-Quarter 2017 Business and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil up around 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Medicines Co. (MDCO) Reports Q3 Loss Per Share of $1.19, Less Than Expected
October 25, 2017 7:10 AM EDTMedicines Co. (NASDAQ: MDCO) reported Q3 EPS of ($1.19), $0.25 better than the analyst estimate of ($1.44). Revenue for the quarter came in at $16.9 million versus the consensus estimate of $24.35 million.
For earnings history and earnings-related data on Medicines Co. (MDCO) click here.
... More